|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|
| Operating activities: | ||||
| Net income (loss) | ||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||||
| Depreciation and amortization | ||||
| Non-cash operating lease costs | ||||
| Stock-based compensation | ||||
| Deferred income taxes | ||||
| Amortization of intangible assets and acquired technology | ||||
| Amortization of debt issuance costs | ||||
| Amortization of investment discount, net of premium | ||||
| Loss on debt refinancing | ||||
| Unrealized gain on remeasurement of debt | ||||
| Debt refinancing costs | ||||
| Changes in operating assets and liabilities: | ||||
| Accounts receivable | ||||
| Prepaid expenses and other assets | ||||
| Accounts payable and accrued liabilities | ||||
| Income taxes payable | ||||
| Deferred revenue | ||||
| Net cash provided by operating activities | ||||
| Investing activities: | ||||
| Purchases of property and equipment | ||||
| Purchases of investments | ||||
| Maturities of investments | ||||
| Sales of investments | ||||
| Business acquisitions, net of cash acquired | ||||
| Other | ||||
| Net cash used in investing activities | ||||
| Financing activities: | ||||
| Proceeds from issuance of common stock upon initial public offering, net of underwriting discounts and offering costs | ||||
| Proceeds from issuance of common stock under employee stock purchase plan | ||||
| Payments of offering costs | ||||
| Payments for dividends related to Class B-2 shares | ||||
| Payments for repurchases of common stock | ||||
| Payment of debt | ||||
| Payment of debt refinancing costs | ||||
| Proceeds from issuance of debt | ||||
| Payment for settlement of vested stock options | ||||
| Payments for taxes related to net share settlement of equity awards | ||||
| Payment of contingent consideration | ||||
| Net activity from derivatives with an other-than-insignificant financing element | ||||
| Proceeds from issuance of shares under equity plans | ||||
| Net cash (used in)/ provided by financing activities | ||||
| Effect of foreign exchange rate changes on cash and cash equivalents | ||||
| Net increase in cash and cash equivalents | ||||
| Cash and cash equivalents at beginning of period | ||||
| Cash and cash equivalents at end of period | ||||
| Supplemental disclosures: | ||||
| Cash paid for interest | ||||
| Cash paid for income taxes, net of refunds | ||||
| Non-cash investing and financing activities: | ||||
| Purchases of property and equipment recorded in accounts payable and accrued liabilities | ||||
| Deferred offering costs payable or accrued but not paid | ||||
Loading...